Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001209191-16-136818

Options or other derivatives

  • Director acquired 191,410 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
MOTT DAVID M Director 2016-08-11 Grant or award · Option to purchase Ordinary Shares +191,410 191,410 D
Loading xslF345X03/doc4.xml…